✦ LIBER ✦

Plexiform neurofibromas

✍ Scribed by Korf, Bruce R.

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 36 KB
Volume: 89
Category: Article
ISSN: 0148-7299
DOI: 10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w

No coin nor oath required. For personal study only.

✦ Synopsis

Plexiform neurofibromas are among the most common and debilitating complications of neurofibromatosis type 1 (NF1). They account for substantial morbidity, including disfigurement, functional impairment, and may even be life threatening. Plexiform neurofibromas are also subject to transformation into malignant peripheral nerve sheath tumor (MPNST), a complication that is refractory to treatment both because of a paucity of effective therapies for malignant soft tissue sarcomas in general, and because of the delay in diagnosis that results from change of a small portion of a large pre-existing tumor. The current mainstay of treatment of plexiform neurofibromas, and of MPNST for that matter, is surgical resection. The major variables are the timing and means of identification of plexiform neurofibromas, methods of follow-up, and indications for surgery. There is no established means of medical treatment, but research into the molecular pathogenesis of NF1, as well as advances in tumor therapy in general, are opening the way towards clinical trials for plexiform neurofibroma.

📜 SIMILAR VOLUMES

Plexiform neurofibroma of the solar plex

Plexiform neurofibroma of the solar plexus

✍ Herbert A. Bruce 📂 Article 📅 1924 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Massive intratumor hemorrhage in facial

Massive intratumor hemorrhage in facial plexiform neurofibroma

✍ Tung-Chain Tung; Yu-Ray Chen; Kuo-Ting Chen; Chien-Tzung Chen; Richard Bendor-Sa 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Background. Plexiform neurofibromatosis is a fea-Recklinghausen's disease (VRD), an autosomal ture of von Recklinghausen's disease. Head and neck lesions may dominant disorder with an incidence of approxiproduce varying degrees of cosmetic and functional deformity. However, life-threatening hemorrha

Clinic-based study of plexiform neurofib

Clinic-based study of plexiform neurofibromas in neurofibromatosis 1

✍ Waggoner, Darrel J.; Towbin, Jennifer; Gottesman, Gary; Gutmann, David H. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB

Individuals with neurofibromatosis 1 (NF1) develop both benign and malignant tumors at an increased frequency. One of the most common benign tumors in NF1 is the plexiform neurofibroma. These tumors cause significant morbidity and mortality on account of their propensity to grow and affect adjacent

NF1 mutations in neurofibromatosis 1 pat

NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas

✍ Lan Kluwe; Reinhard E. Friedrich; Bruce Korf; Raimund Fahsold; Victor-F. Mautner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Neurofibromatosis 1 (NF1) is an autosomal dominant disorder caused by genetic alterations of the NF1 gene on 17q11.2. About 30% of NF1 patients develop plexiform neurofibromas (PNFs), which often cause severe clinical deficits. To determine whether there is a certain genotype underlying PNFs or subt

Germline and somatic NF1 gene mutations

Germline and somatic NF1 gene mutations in plexiform neurofibromas

✍ Meena Upadhyaya; Gill Spurlock; Bisma Monem; Nick Thomas; Reinhard E. Friedrich; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Neurofibromatosis type 1 (NF1), a common autosomal dominant neurogenetic disorder affecting 1 in 4000 individuals worldwide, results from functional inactivation of the 17q11.2-located NF1 gene. Plexiform neurofibroma (PNF) is a congenital benign tumour present in 30-50% of NF1 patients, which in ab

Management issues in massive pediatric f

Management issues in massive pediatric facial plexiform neurofibroma with neurofibromatosis type 1

✍ Jeffrey B. Wise; Snehal G. Patel; Jatin P. Shah 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract ## Background Plexiform neurofibroma is a relatively common but potentially devastating manifestation of neurofibromatosis type 1 (NF1). Surgical management is the mainstay of therapy, but within the head and neck region it is limited by the infiltrating nature of these tumors, inheren